Point72 Asset Management’s Amylyx Pharmaceuticals AMLX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $29.1M | Buy |
4,536,266
+3,619,300
| +395% | +$23.2M | 0.06% | 328 |
|
|
2025
Q1 | $3.25M | Buy |
+916,966
| New | +$3.25M | 0.01% | 728 |
|
|
2024
Q4 | – | Sell |
-200
| Closed | -$648 | – | 1261 |
|
|
2024
Q3 | $648 | Buy |
+200
| New | +$648 | ﹤0.01% | 1178 |
|
|
2024
Q2 | – | Sell |
-170,000
| Closed | -$483K | – | 1183 |
|
|
2024
Q1 | $483K | Sell |
170,000
-2,581,305
| -94% | -$7.33M | ﹤0.01% | 1031 |
|
|
2023
Q4 | $40.5M | Buy |
2,751,305
+2,751,259
| +5,980,998% | +$40.5M | 0.1% | 246 |
|
|
2023
Q3 | $842 | Sell |
46
-7,061
| -99% | -$129K | ﹤0.01% | 1683 |
|
|
2023
Q2 | $153K | Sell |
7,107
-317,693
| -98% | -$6.85M | ﹤0.01% | 987 |
|
|
2023
Q1 | $9.53M | Sell |
324,800
-1,803,160
| -85% | -$52.9M | 0.03% | 501 |
|
|
2022
Q4 | $78.6M | Buy |
2,127,960
+1,660,999
| +356% | +$61.4M | 0.27% | 85 |
|
|
2022
Q3 | $13.1M | Buy |
466,961
+154,500
| +49% | +$4.35M | 0.05% | 407 |
|
|
2022
Q2 | $6.02M | Buy |
+312,461
| New | +$6.02M | 0.03% | 573 |
|